Gene therapy approval advances for Duchenne MD | Psychotherapy for depression in pregnancy | Child neglect links to poor health later | Protection against eye injury
Listen now
Description
The U.S. Food and Drug Administration (FDA) have voted that when they meet formally at the end of May, approval goes forward for a treatment for Duchenne muscular dystrophy—a disabling genetic disease. Post partum depression is a significant issue for both women and their babies, and it doesn't come out of the blue—depression can occur before or during pregnancy. Child neglect leads to both later poor physical health—with things like inflammation—and mental health, such as depression. Would you wear protective eyewear to play tennis, badminton or Aussie Rules?
More Episodes
Humans spend around a third of their lives sleeping, and its management has created a multi-million dollar industry. We discuss the sleep of FIFO workers, the sleep of people with PTSD, and what we can do to improve our shut-eye time with a therapy called circadian medicine.
Published 09/18/23
A clearer picture of where and how mistakes are made in medical diagnoses. Monkeys on some Caribbean islands are helping researchers understand more about addiction. Sydney's Liverpool Hospital developed a program using gaming to spur on patients recovering from traumatic brain injury.
Published 09/11/23